Skip to content
Homepage
Clinic directory

Clinics in Boston, Massachusetts

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Boston, MA

Stem Cell Therapy clinics in Boston

Boston supports a regenerative medicine market shaped by both private clinics and regional academic medicine. Local referral networks run through Massachusetts General Hospital, Brigham and Women's, Beth Israel Deaconess, and Boston Children's, and stem cell practice in the area spans the Longwood Medical Area, Back Bay, and Cambridge border. Patient demand splits across three buckets: orthopedic injections for active adults and aging athletes, neurological and autoimmune protocols marketed to longevity-focused patients, and IV-based allogeneic products offered by private wellness clinics. The FDA classifies most stem cell injections for orthopedic, neurological, or longevity use as investigational biologics under 21 CFR Part 1271, meaning they require either a Biologics License or an active Investigational New Drug authorization. Autologous bone marrow and adipose products may qualify as Section 361 when minimally manipulated and used for homologous function. Massachusetts regulates physician practice through the Board of Registration in Medicine. There is no state-specific stem cell statute, so federal 21 CFR Part 1271 rules apply. Harvard-affiliated hospitals and MIT anchor the region's academic trial infrastructure. The 4 Boston clinics listed below have been reviewed against our vetting criteria, including federal NPI lookup, OIG exclusion screening, and Massachusetts Board of Registration in Medicine licensure checks.

2 Clinics

MD on staff

Ortho Therapeutics and Wellness

Boston, MA

Ortho Therapeutics and Wellness, a regenerative medicine clinic in Boston, specializes in orthobiologic and cell-based therapies for musculoskeletal pain and joint conditions. The practice offers pla…

  • PRP Therapy
  • Arthritis Treatment
  • Stem Cell Therapy
 MD on staff

Leonard Hair Transplant Associates

Boston, MA

Leonard Hair Transplant Associates, in Boston, specializes in hair restoration using both surgical transplantation and platelet-rich plasma therapy. The clinic combines traditional hair-transplant pr…

  • PRP Therapy
  • Stem Cell Therapy
15 30 50 results per page

Regulatory context

A note on Massachusetts's stem cell therapy rules.

Massachusetts cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Massachusetts for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. The state hosts substantial academic and industry regenerative medicine research, much of which proceeds under FDA-cleared INDs and BLAs.

  • Massachusetts Medical Practice Act, MGL Chapter 112, Sections 2-9
    Establishes physician licensure and discipline through the Massachusetts Board of Registration in Medicine.
  • Massachusetts Pharmacy Act, MGL Chapter 112, Sections 24-42A and 247 CMR
    Regulates compounding pharmacies aligned with federal 503A and 503B standards. Massachusetts strengthened oversight after the 2012 NECC outbreak.
  • Massachusetts Consumer Protection Act, MGL Chapter 93A
    Empowers the Attorney General and private plaintiffs to pursue deceptive marketing claims against providers making unsupported clinical claims.

The FDA has corresponded with Massachusetts providers offering cellular therapies. The Massachusetts Board of Registration in Medicine has disciplined physicians for unprofessional conduct including misleading regenerative medicine marketing. The Massachusetts Attorney General has used Chapter 93A aggressively against deceptive health claims, and Chapter 93A also enables private class actions. The 2012 New England Compounding Center fungal meningitis outbreak left Massachusetts with one of the strictest pharmacy compounding oversight regimes in the country. Stem cell clinics sourcing biologics from out-of-state pharmacies face elevated scrutiny.

Sources: fda.gov · mass.gov · mass.gov

Stem Cell Therapy in Boston, answered.

Most stem cell therapies at private Boston clinics are not FDA-approved. The FDA has approved certain hematopoietic stem cell products for blood and immune disorders, but stem cell injections for orthopedic, neurological, or longevity use are generally investigational. They require a Biologics License or an active Investigational New Drug authorization, or they must qualify as Section 361 minimally manipulated and homologous-use products under 21 CFR Part 1271. Massachusetts regulates physician practice through the Board of Registration in Medicine.

Boston sits in the premium metro tier. Single-joint autologous bone marrow or adipose injections typically run $5,000 to $15,000 per session. Systemic IV protocols using allogeneic umbilical cord or Wharton's jelly products range $10,000 to $25,000, and full multi-session protocols can reach $20,000 to $50,000. Exosome add-ons range $4,000 to $8,000. Insurance rarely covers these treatments because the FDA classifies most protocols as investigational.

Autologous stem cells come from your own body, usually harvested from bone marrow aspirate or adipose tissue and reinjected the same day. When minimally manipulated and used for homologous function, they often fall under FDA Section 361, which does not require pre-market approval. Allogeneic stem cells come from a donor source, most commonly umbilical cord blood or Wharton's jelly, and are generally classified as Section 351 biologics that require an active Investigational New Drug authorization. Boston clinic offerings span both categories, so ask which classification applies before treatment.

Yes. Research programs at Massachusetts General Hospital, Brigham and Women's, Beth Israel Deaconess, and Boston Children's periodically run FDA-authorized stem cell trials across orthopedics, neurology, cardiology, and oncology. Search clinicaltrials.gov and filter by Boston or the broader metro to see active recruiting studies. Trial participation is typically low-cost or free compared to commercial protocols and includes structured follow-up with imaging and lab monitoring.

Verify physician licensure through the Massachusetts Board of Registration in Medicine and confirm the clinic's NPI number through the NPPES registry. Check the FDA warning letter database for the clinic name and the HHS Office of Inspector General exclusion list. Ask whether the treatment is Section 361 or Section 351, whether the clinic operates under an Investigational New Drug authorization for allogeneic or expanded products, and whether adverse events are tracked. Ask specifically about compliance with federal 21 CFR 1271.

Treatment guide

Learn about Stem Cell Therapy

What it is, how it works, and what to expect.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology